AHRP Speaks Out


AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00. […]

AHRP Position Statement on Mental Health Screening – FDA Hearing ...


AHRP Letter to Editor re: ARDS published NEJM Fri, 11 Jul 2003 A truncated version of a Letter to the editor submitted by John H. Noble, Jr., PhD and Vera Sharav appears in the current July 10, 2003, issue of The New England Journal of Medicine. Note: On April 3, […]

AHRP Letter to Editor re: ARDS published NEJM


INTRODUCTION: This bill seriously endangers, if not completely undermines, the democratic process and the rule of law. It will absolutely destroy the unalienable rights of trial by jury and informed consent. It is a radical transfer of the US Treasury into the hands of unaccountable private companies whose record shows far more concern about profits than in protecting and improving the health of the American people. It also concentrates the power of life and death in the hands of one very fallible human being and creates an unaccountable federal bureaucracy not subject to disclosure, independent oversight or the safeguards of accountability necessary in a free republic.

Analysis of S. 1873 – The Biodefense and Pandemic Vaccine ...



The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question "What is the Best Way to Protect Children?"

Our recommendation - which is backed up by evidence that children have suffered harm in medical research - is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.

We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment - as required under the provisions of 46.407.

Statement of the AHRP Opposing the SACHRP Children's Committee Recommendations


My name is Vera Hassner Sharav, and I am president of The Alliance for Human Research Protection: a national human rights organization that exposes unethical research practices which undermine the dignity, rights, and safety of human subjects.

In 1947, an American military tribunal sat in judgment of the Nazi doctors at Nuremberg, and laid down ten essential principles that define "permissible medical experiments" in a civilized society. Those principles are enshrined in the Nuremberg Code which is the cornerstone of all medical research ethics. The nations of the world adopted the Code as a safeguard to prevent future medical atrocities.

Statement by Vera Hassner Sharav, Anthrax Band Reunion Press Conference


When a federal judge ruled the vaccine to be an "investigational drug and a drug being used for an unapproved purpose" on December 22, 2003, FDA hurriedly issued a Final Rule for anthrax vaccine. The agency submitted its Final Rule just eight days after a federal court injunction, having failed to do so for 19 years. In a January 7, 2004 court hearing the same judge called FDA's actions "highly suspicious." On October 27, 2004 FDA's arbitrary and capricious promulgation of this Final Rule resulted in a permanent injunction, remanding the license to your agency to complete according to the law. The injunction also halted what the judge called DoD's "illegal" mandatory anthrax vaccination program.

AHRP Ethical and Scientific Objections to FDA's Proposed Licensure of ...



The Washington Post reports (below) that the Environmental Protection Agency (EPA) announced plans to enroll 60 young children in Duval County, Florida - infants to age 3 - exposing them to pesticides to study how the children absorb poisonous chemicals!

In this experiment children will literally be relegated to the status of human guinea pigs. This experimental abuse of children demonstrates what the chemical / pharmaceutical industry buys when it "contributes" funds to government agencies, public officials, scientists and academic institutions.

US Gov Pesticide Exposure Experiments: Target Children–$970 per child – ...


We are witnessing the unraveling of a system that was intended to ensure that marketed drugs met high safety standards; that physicians were informed about potential, serious adverse drug effects - so that they would prescribe judiciously; and that the integrity of the scientific literature was preserved. But that system has been hijacked by the drug industry - which has infected medical practice and medical research with detail men and informercials that make false claims while manipulating partial data to conceal adverse drug effects.

Press Statement – FDA & Concealment of Suicide-Related Risks of ...


Scientists' Presentations at AHRP Press Briefing in Conjunction with FDA Hearings:

  • Peter Mansfield, MD, University of Adelaide (Australia), Director of Healthy Skepticism discussed the illusion of potency in light of the meta-analyses in the British Medical Journal (which he co-authored) and the Lancet.
    Dr. Mansfield's power point presentation
  • Peter Breggin, MD, a psychiatrist with a sub-specialty in clinical psychopharmacology, who was among the first to recognize adverse antidepressant drug reactions
    Dr. Breggin's presentation
  • Lawrence Diller, MD, a pediatrician and family therapist who has evaluated and treated more than 2,500 children
    Dr. Diller's presentation
  • Stefan Kruszewski, MD, a clinical and academic psychiatrist, and Associate Medical Director of Physicians' Health Programs, Pennsylvania Medical Society
    Dr. Kruszewski's presentation
  • David Healy, MD, Director of the North Wales Department of Psychological Medicine and Visiting Professor, University of Toronto,

AHRP Press Briefing: Antidepressants and Suicide-Related Risks for Children



Today's (6/30/04) editorial, "Missing Drug Data," misses the point and argues with the pharmaceutical industry and its allies in the Congress, the NIH and the FDA that data can be selectively reported to satisfy commercial interests. This is a blatant attack on Karl Popper's falsifiability principle on which empirical science depends to make progress. One needs all the data in order to verify the results of clinical or any other kind of research. Most academics and pundits know that any case can be made if allowed to manipulate the data and assumptions. The AMA, the medical journal editors, and Eliot Spitzer, all deserve applause from the Washington Post editor-not quibbling about the possible damage that somehow, somewhere might result from strict embrace of the principles and practice of scientific inquiry. It's all about transparency.

John H. Noble, Jr.

Response to Washington Post Editorial "Missing Drug Data"